| Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs KY Win, SS Feng Biomaterials 26 (15), 2713-2722, 2005 | 1813 | 2005 |
| A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS L Mu, SS Feng Journal of controlled release 86 (1), 33-48, 2003 | 1070 | 2003 |
| Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery SA Kulkarni, SS Feng Pharmaceutical research 30, 2512-2522, 2013 | 838 | 2013 |
| Vitamin E TPGS as a molecular biomaterial for drug delivery Z Zhang, S Tan, SS Feng Biomaterials 33 (19), 4889-4906, 2012 | 646 | 2012 |
| Nanotheranostics˗ application and further development of nanomedicine strategies for advanced theranostics MS Muthu, DT Leong, L Mei, SS Feng Theranostics 4 (6), 660, 2014 | 630 | 2014 |
| Methoxy poly (ethylene glycol)-poly (lactide)(MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs Y Dong, SS Feng Biomaterials 25 (14), 2843-2849, 2004 | 607 | 2004 |
| Poly (d, l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs Y Dong, SS Feng Biomaterials 26 (30), 6068-6076, 2005 | 556 | 2005 |
| Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases SS Feng, S Chien Chemical Engineering Science 58 (18), 4087-4114, 2003 | 536 | 2003 |
| Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers S Feng, G Huang Journal of Controlled Release 71 (1), 53-69, 2001 | 534 | 2001 |
| The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)–tocopheryl polyethylene glycol succinate … Z Zhang, SS Feng Biomaterials 27 (21), 4025-4033, 2006 | 507 | 2006 |
| Preparation and characterization of poly (lactic acid)–poly (ethylene glycol)–poly (lactic acid)(PLA–PEG–PLA) microspheres for controlled release of paclitaxel G Ruan, SS Feng Biomaterials 24 (27), 5037-5044, 2003 | 486 | 2003 |
| Pharmaceutical nanotechnology for oral delivery of anticancer drugs L Mei, Z Zhang, L Zhao, L Huang, XL Yang, J Tang, SS Feng Advanced drug delivery reviews 65 (6), 880-890, 2013 | 452 | 2013 |
| Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®) L Mu, SS Feng Journal of Controlled Release 80 (1-3), 129-144, 2002 | 448 | 2002 |
| Nanoparticles of biodegradable polymers for clinical administration of paclitaxel SS Feng, L Mu, KY Win, G Huang Current Medicinal Chemistry 11 (4), 413-424, 2004 | 416 | 2004 |
| Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel Y Liu, K Li, J Pan, B Liu, SS Feng Biomaterials 31 (2), 330-338, 2010 | 390 | 2010 |
| Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid … L Mu, SS Feng Journal of Controlled Release 76 (3), 239-254, 2001 | 376 | 2001 |
| Subnuclear organization of the rat habenular complexes KH Andres, MV Düring, RW Veh Journal of Comparative Neurology 407 (1), 130-150, 1999 | 366* | 1999 |
| Poly (lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel SS Feng, L Mei, P Anitha, CW Gan, W Zhou Biomaterials 30 (19), 3297-3306, 2009 | 363 | 2009 |
| Multifunctional poly (D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer B Sun, B Ranganathan, SS Feng Biomaterials 29 (4), 475-486, 2008 | 353 | 2008 |
| Folate-decorated poly (lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery Z Zhang, SH Lee, SS Feng Biomaterials 28 (10), 1889-1899, 2007 | 329 | 2007 |
Prof. M.S. Muthu, Ph.D., FRSC., MNASc.Professor in Pharmaceutics, Department of Pharm. Engg and Tech. Indian Institute of Technology (BHU)Dirección de correo verificada de iitbhu.ac.in
